| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | -0.08 | 0.02 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | TGX221 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.02 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | PIK-93 | GDSC1000 | pan-cancer | AAC | -0.066 | 0.02 |
| mRNA | TGX221 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.02 |
| mRNA | Elesclomol | GDSC1000 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.03 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.075 | 0.03 |